medicine

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Ge

SINGAPORE (June 19): iX Biopharma says the Australia’s regulatory authority, Therapeutic Goods Administration (TGA), has given the go-ahead for the use of Wafesil to treat of male erectile dysfunction in the country.

SINGAPORE (June 20): Pain conditions are costing Southeast Asian economies about US$44.6 billion ($61.9 billion) in productivity losses on an annual basis – out of which Singapore’s estimated productivity losses make up about US$6.2 billion per year,

SINGAPORE (March 31): At least one observer has held up Singapore’s healthcare system as a model for the developed world. But the system is not without its own issues.

SINGAPORE (Jan 10): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 63 cents following the recent news of the group’s expansion into Vietnams’ private healthcare market.

BEIJING (Jan 6): The thick haze of pollution blanketing northern China this winter is a grim reminder of the nation’s new growth industry: lung cancer drugs.